Pharmaceuticals Lipids Market Set to Soar, Reaching $7.07 Billion by 2030: Revolutionizing Drug Formulation and Solubility Enhancement New York, United States, Oct. 11, 2023 (GLOBE NEWSWIRE) -- In pharmaceutical industry, lipids and polymers are considered two of the essential excipients used to produce drugs. Stabilizers,...

Elevar Therapeutics Names Dr. Chris Galloway Vice President of Clinical Development FORT LEE, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...

Elevar Therapeutics Debuts New Corporate Headquarters in Fort Lee, New Jersey FORT LEE, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...

Elevar Therapeutics Names Wade Smith Chief Financial Officer SALT LAKE CITY, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...